Myeloma Trial, Recruiting NCT06960993 Sponsor: Northwestern University Condition: Myeloma
Back to Myeloma

Myeloma Trial, Recruiting

NCT06960993
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a blood cancer, as confirmed in their medical records
  • People who are scheduled for, or in the process of scheduling, a stem cell transplant (using either their own cells or cells from a donor) at one of the participating study locations
  • People aged 18 or older, with no upper age limit
  • People who are proficient in English or Spanish
  • People who are interested in using a website to learn about stem cell transplant
  • People who are willing and able to understand and sign a consent form and follow all study procedures

Who may not be able to join:

  • People who are currently taking part in another program specifically designed to help with emotional distress, quality of life, or symptoms
  • People who are about to undergo the first of two planned back-to-back stem cell transplants (known as a tandem transplant)
  • People who are unable to give meaningful consent due to severe cognitive impairment or significant language difficulties

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 312-503-7715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 April 2025
Est. completion
12 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Improvement in general psychological distress

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov